BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26714866)

  • 1. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement.
    Alawieh A; Elvington A; Zhu H; Yu J; Kindy MS; Atkinson C; Tomlinson S
    J Neuroinflammation; 2015 Dec; 12():247. PubMed ID: 26714866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.
    Elvington A; Atkinson C; Zhu H; Yu J; Takahashi K; Stahl GL; Kindy MS; Tomlinson S
    J Immunol; 2012 Nov; 189(9):4640-7. PubMed ID: 23028050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
    Huang Y; Qiao F; Atkinson C; Holers VM; Tomlinson S
    J Immunol; 2008 Dec; 181(11):8068-76. PubMed ID: 19017999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
    Rohrer B; Long Q; Coughlin B; Wilson RB; Huang Y; Qiao F; Tang PH; Kunchithapautham K; Gilkeson GS; Tomlinson S
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3056-64. PubMed ID: 19264882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.
    Atkinson C; He S; Morris K; Qiao F; Casey S; Goddard M; Tomlinson S
    J Immunol; 2010 Dec; 185(11):7007-13. PubMed ID: 20962256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.
    Neher MD; Rich MC; Keene CN; Weckbach S; Bolden AL; Losacco JT; Patane J; Flierl MA; Kulik L; Holers VM; Stahel PF
    J Neuroinflammation; 2014 May; 11():95. PubMed ID: 24885042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-dependent P-selectin expression and injury following ischemic stroke.
    Atkinson C; Zhu H; Qiao F; Varela JC; Yu J; Song H; Kindy MS; Tomlinson S
    J Immunol; 2006 Nov; 177(10):7266-74. PubMed ID: 17082645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury.
    Alawieh A; Langley EF; Weber S; Adkins D; Tomlinson S
    J Neurosci; 2018 Mar; 38(10):2519-2532. PubMed ID: 29437855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.
    Sekine H; Kinser TT; Qiao F; Martinez E; Paulling E; Ruiz P; Gilkeson GS; Tomlinson S
    Arthritis Rheum; 2011 Apr; 63(4):1076-85. PubMed ID: 21452327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
    Banda NK; Levitt B; Glogowska MJ; Thurman JM; Takahashi K; Stahl GL; Tomlinson S; Arend WP; Holers VM
    J Immunol; 2009 Nov; 183(9):5928-37. PubMed ID: 19828624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
    Atkinson C; Song H; Lu B; Qiao F; Burns TA; Holers VM; Tsokos GC; Tomlinson S
    J Clin Invest; 2005 Sep; 115(9):2444-53. PubMed ID: 16127466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
    Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
    Qiu S; Liu N; Jia L; Yang G; Su W; Li J; Song L; Yang C; Wang J; Zhang C; Wang Z; Qiao F; Tomlinson S; Atkinson C; Sun Y; Huang L; Song H; Wang Y; Li Z
    Virol J; 2012 Nov; 9():285. PubMed ID: 23173749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy.
    Marshall KM; He S; Zhong Z; Atkinson C; Tomlinson S
    J Exp Med; 2014 Aug; 211(9):1793-805. PubMed ID: 25113972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
    Guo Z; Chen J; Zeng Y; Wang Z; Yao M; Tomlinson S; Chen B; Yuan G; He S
    Front Immunol; 2021; 12():785287. PubMed ID: 35069557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis.
    Elvington M; Schepp-Berglind J; Tomlinson S
    Clin Exp Immunol; 2015 Mar; 179(3):500-8. PubMed ID: 25293413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.
    Parsons N; Annamalai B; Obert E; Schnabolk G; Tomlinson S; Rohrer B
    Mol Immunol; 2019 Apr; 108():8-12. PubMed ID: 30763805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis.
    Schepp-Berglind J; Atkinson C; Elvington M; Qiao F; Mannon P; Tomlinson S
    J Immunol; 2012 Jun; 188(12):6309-18. PubMed ID: 22566568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
    Qiao F; Atkinson C; Song H; Pannu R; Singh I; Tomlinson S
    Am J Pathol; 2006 Sep; 169(3):1039-47. PubMed ID: 16936276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model.
    Parsons NB; Annamalai B; Rohrer B
    Transl Vis Sci Technol; 2023 Jul; 12(7):17. PubMed ID: 37462980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.